-
Innovation at the Intersections: How Luna Labs Creates Breakthrough Solutions for Patients and Warfighters
What makes Luna Labs different in biomedical innovation? Biotech Division managers, Lauren Costella and Kelley Virgilio, reveal the company's unique approach to tackling complex biotech challenges.
Categories
Tags
-
Flexible Electrodes for Better Connections to Damaged Nerves
Our flexible electrodes create better connections so damaged nerves can send and receive messages more effectively.
Categories
-
Luminoah: From Urgent Need to Critical Solution
Insights from our recent interview with Luminoah CEO, Neal Piper. He describes how he and his team built a medical device company from a deeply personal experience.
Categories
-
Luna Labs Expands Operations in Charlottesville
Luna Labs will invest $200,000 to expand product development capabilities and create new jobs.
Categories
-
Rapid Detection of PTSD-Associated DNA Methylation
Our EpiNanoSPRi technology is a simpler way to detect epigenetic modifications related to PTSD, with the potential for faster diagnosis and treatment.
Categories
Tags
-
Advancing Post-Operative Care Through Strategic Partnership
Working with Parimer Scientific, AeroVeil is closer to clinical use to reduce post-operative adhesions - a leading cause of infertility in women.
Categories
Tags
-
Breaking New Ground in Vaccine Development
We're pleased to share insights from our recent interview with our collaborator, Dr. Moriya Tsuji, who discusses strategies for enhancing T cell responses for advanced vaccine development.
Categories
Tags
-
What do these technologies have in common?
Get a glimpse at the broad expertise of our scientists and engineers who are tackling challenging health and safety concerns.
Categories
-
Short Carbon Nanotubes Hold Big Promise for the Future of Healthcare Delivery Platforms
Yang Xu, PhD, explains how nanotechnologies, especially SCNTs, are medical game-changers.
Categories
Tags
-
A Layer-by-Layer Look at the Future of Vaccine Delivery
Chris Tison, PhD, explains how new vaccine technologies, based on layer-by-layer and SCNTs delivery platforms, will improve how future vaccines are administered.
Categories
Tags